Print Page  |  Close Window

Overview

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries.

MEDP (Common Stock)
$33.59
Change (%)  -0.01 (0.03%)
Volume 24,102
Date as of  10/18/17 1:50 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: MEDP.O.  Currently trading at $33.59 with a 52 week high of $38.94 and a 52 week low of $21.76.

Upcoming Events

Tuesday, October 31, 2017 9:00 a.m. ETQ3 2017 Medpace Holdings, Inc. Earnings Conference Call

View all events

Primary IR Contact

Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
Phone: +1.513.579.9911
investor@medpace.com